WO2013048140A3 - Composition for suppressing nerve cells, containing phragmitis rhizoma extracts, and use thereof - Google Patents
Composition for suppressing nerve cells, containing phragmitis rhizoma extracts, and use thereof Download PDFInfo
- Publication number
- WO2013048140A3 WO2013048140A3 PCT/KR2012/007817 KR2012007817W WO2013048140A3 WO 2013048140 A3 WO2013048140 A3 WO 2013048140A3 KR 2012007817 W KR2012007817 W KR 2012007817W WO 2013048140 A3 WO2013048140 A3 WO 2013048140A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nerve cells
- composition
- phragmitis rhizoma
- rhizoma extracts
- extracts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to Phragmitis Rhizoma extracts that can suppress variation in central nerves caused by an exposure to electromagnetic waves, and more particularly, to a functional food composition for suppressing damage to nerve cells caused by electromagnetic waves or a pharmaceutical composition for preventing and treating neurological disorders, containing Phragmitis Rhizoma extracts as active ingredients. The functional food composition or pharmaceutical composition, containing Phragmitis Rhizoma extracts, according to the present invention may suppress damage to nerve cells and therefore may be valuably used for purposes of preventing and treating neurological disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110097705A KR101203194B1 (en) | 2011-09-27 | 2011-09-27 | Inhibitory effect of Phragmitis Rhizoma extract on electromagnetic field-induced change in central nervous system |
KR10-2011-0097705 | 2011-09-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013048140A2 WO2013048140A2 (en) | 2013-04-04 |
WO2013048140A3 true WO2013048140A3 (en) | 2013-05-23 |
Family
ID=47565058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/007817 WO2013048140A2 (en) | 2011-09-27 | 2012-09-27 | Composition for suppressing nerve cells, containing phragmitis rhizoma extracts, and use thereof |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101203194B1 (en) |
WO (1) | WO2013048140A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101818500B1 (en) * | 2016-02-18 | 2018-01-15 | 한국 한의학 연구원 | Composition for preventing, improviong or treating disease caused by side effect of anticancer agent comprising Phragmites communis Trin extract as effective component |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100285206B1 (en) * | 1998-01-06 | 2001-03-15 | 황무연 | Root extract and manufacturing method |
KR20110020350A (en) * | 2009-08-24 | 2011-03-03 | 최진호 | A memory improving agent developed from components of red ginseng and reed root, a preparation method thereof, and food compositions enhanced functionality containing the same |
-
2011
- 2011-09-27 KR KR1020110097705A patent/KR101203194B1/en active IP Right Grant
-
2012
- 2012-09-27 WO PCT/KR2012/007817 patent/WO2013048140A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100285206B1 (en) * | 1998-01-06 | 2001-03-15 | 황무연 | Root extract and manufacturing method |
KR20110020350A (en) * | 2009-08-24 | 2011-03-03 | 최진호 | A memory improving agent developed from components of red ginseng and reed root, a preparation method thereof, and food compositions enhanced functionality containing the same |
Non-Patent Citations (2)
Title |
---|
A. JELENKOVIC ET AL.: "Effects of extremely low-frequency magnetic field in the brain of rats", BRAIN RESEARCH BULLETIN, vol. 68, 2006, pages 355 - 360, XP024900818 * |
JIN-HO, CHOI ET AL.: "Effect of reed root extract(RRE) on learning and memory impairment animal model SAMP8 strain", KOREAN JOURNAL OF GERONTOLOGY, vol. 7, no. 3, 1997, pages 23 - 28 * |
Also Published As
Publication number | Publication date |
---|---|
KR101203194B1 (en) | 2012-11-21 |
WO2013048140A2 (en) | 2013-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014062691A3 (en) | Compositions for modulating c9orf72 expression | |
PH12015500879A1 (en) | Compositions and methods for treating proteinopathies | |
WO2012157978A3 (en) | Daphne genkwa extracts, and pharmaceutical composition containing fractions of the extracts or compounds separated from the extracts as active ingredients for preventing or treating atopic dermatitis | |
WO2012104007A3 (en) | 7-azaindole derivatives | |
WO2011090270A3 (en) | Composition containing osmotin for preventing and treating neurological disorders | |
MX2014010563A (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production. | |
WO2013119946A8 (en) | Long chain base sphingosine kinase inhibitors | |
PH12017500706A1 (en) | Composition containing extract or fraction of genus justicia plant | |
WO2011049327A3 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
SA113340494B1 (en) | Composition for treating metabolic disorders | |
WO2014083422A3 (en) | Treating soluble coffee | |
EP2575842A4 (en) | A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases | |
WO2013057592A3 (en) | Treatment of sickle cell disease | |
EP2910247A4 (en) | Compositions for preventing or treating allergic skin disorders, containing gpcr19 agents as active ingredients | |
WO2010009809A3 (en) | Active substance combinations consisting of an anis fruit extract and hyaluronic acid | |
WO2012108749A3 (en) | Composition and health functional food for treating brain cancer comprising pharbitidis semen extract | |
WO2016186349A3 (en) | Composition, containing quisaqualis indica extract, for preventing or treating prostatic hyperplasia | |
WO2013000895A9 (en) | Dha and epa in the reduction of oxidative stress | |
WO2013100718A3 (en) | Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient | |
WO2012134172A3 (en) | Composition containing, as an active ingredient, an ethyl acetate fraction of schisandra chinensis baill, or wuweizisu c separated from the fraction, for preventing or treating obesity | |
WO2012108748A3 (en) | Composition and cosmetic composition for treating brain cancer comprising albizzia julibrissin extract | |
WO2013048140A3 (en) | Composition for suppressing nerve cells, containing phragmitis rhizoma extracts, and use thereof | |
WO2011112002A3 (en) | Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient | |
WO2013005956A3 (en) | Pharmaceutical composition and food composition for preventing and ameliorating intestinal motility disorders | |
WO2012108747A3 (en) | Composition and cosmetic composition for treating brain cancer comprising helena root extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12836667 Country of ref document: EP Kind code of ref document: A2 |